Perioperative mepolizumab in aspirin-exacerbated respiratory disease does not prevent nasal polyp regrowth.
作者信息
Supron Andrew D, Bergmark Regan W, Roditi Rachel E, Buchheit Kathleen M
机构信息
Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
Department of Otolaryngology-Head and Neck Surgery, Harvard Medical School, Boston, Massachusetts; Center for Surgery and Public Health, Brigham and Women's Hospital, Boston, Massachusetts.
出版信息
Ann Allergy Asthma Immunol. 2023 Sep;131(3):384-386. doi: 10.1016/j.anai.2023.06.017. Epub 2023 Jun 17.
Abstract
摘要
相似文献
1
Perioperative mepolizumab in aspirin-exacerbated respiratory disease does not prevent nasal polyp regrowth.阿司匹林加重性呼吸道疾病围手术期使用美泊利单抗不能预防鼻息肉再生。
Ann Allergy Asthma Immunol. 2023 Sep;131(3):384-386. doi: 10.1016/j.anai.2023.06.017. Epub 2023 Jun 17.
2
Decreased nasal polyp eosinophils but increased mast cells in a patient with aspirin-exacerbated respiratory disease treated with reslizumab.在用瑞利珠单抗治疗的阿司匹林加重性呼吸系统疾病患者中，鼻息肉嗜酸性粒细胞减少但肥大细胞增多。
Ann Allergy Asthma Immunol. 2020 Oct;125(4):490-493.e2. doi: 10.1016/j.anai.2020.06.043. Epub 2020 Jul 4.
3
Co-treatment of non-steroidal anti-inflammatory drug-exacerbated respiratory disease with dupilumab and aspirin therapy after desensitization.脱敏后使用度普利尤单抗和阿司匹林治疗非甾体抗炎药加重的呼吸道疾病的联合治疗。
Clin Exp Allergy. 2023 Sep;53(9):974-977. doi: 10.1111/cea.14348. Epub 2023 May 29.
4
Mepolizumab for chronic rhinosinusitis with nasal polyps: Treatment efficacy by comorbidity and blood eosinophil count.美泊利珠单抗治疗伴有鼻息肉的慢性鼻-鼻窦炎：基于合并症和血嗜酸性粒细胞计数的治疗疗效。
J Allergy Clin Immunol. 2022 May;149(5):1711-1721.e6. doi: 10.1016/j.jaci.2021.10.040. Epub 2022 Jan 7.
5
Effects of Reslizumab on Asthma Outcomes in a Subgroup of Eosinophilic Asthma Patients with Self-Reported Chronic Rhinosinusitis with Nasal Polyps.瑞利珠单抗在伴有鼻息肉的慢性鼻-鼻窦炎并自我报告的嗜酸性粒细胞性哮喘患者亚组中的哮喘结局的影响。
J Allergy Clin Immunol Pract. 2019 Feb;7(2):589-596.e3. doi: 10.1016/j.jaip.2018.08.021. Epub 2018 Sep 5.
6
Nasal expression of the vascular endothelial growth factor and its receptors is reduced by mepolizumab in chronic rhinosinusitis with nasal polyposis.在伴有鼻息肉的慢性鼻-鼻窦炎中，美泊利珠单抗可降低血管内皮生长因子及其受体的鼻腔表达。
Ann Allergy Asthma Immunol. 2021 Apr;126(4):442-443. doi: 10.1016/j.anai.2021.01.010. Epub 2021 Jan 16.
7
Current and future treatment options for adult chronic rhinosinusitis: Focus on nasal polyposis.成人慢性鼻-鼻窦炎的当前和未来治疗选择：关注鼻息肉。
J Allergy Clin Immunol. 2015 Dec;136(6):1431-1440. doi: 10.1016/j.jaci.2015.10.010.
8
Mepolizumab for chronic rhinosinusitis with nasal polyps.美泊利单抗用于治疗伴有鼻息肉的慢性鼻-鼻窦炎
Lancet Respir Med. 2021 Oct;9(10):1081-1082. doi: 10.1016/S2213-2600(21)00133-8. Epub 2021 Apr 16.
9
Controversies in Allergy: Aspirin Desensitization or Biologics for Aspirin-Exacerbated Respiratory Disease-How to Choose.过敏争议：阿司匹林脱敏还是生物制剂治疗阿司匹林加重的呼吸道疾病-如何选择。
J Allergy Clin Immunol Pract. 2022 Jun;10(6):1462-1467. doi: 10.1016/j.jaip.2021.12.030. Epub 2022 Jan 6.
10
The Role of Biologics in Chronic Rhinosinusitis With Nasal Polyps.生物制剂在慢性鼻-鼻窦炎伴鼻息肉中的作用。
Ear Nose Throat J. 2021 Jan;100(1):44-47. doi: 10.1177/0145561320964653. Epub 2020 Oct 9.
引用本文的文献
1
New insights into the mechanisms of aspirin-exacerbated respiratory disease.阿司匹林诱发的呼吸道疾病发病机制的新见解
Curr Opin Allergy Clin Immunol. 2025 Feb 1;25(1):41-46. doi: 10.1097/ACI.0000000000001051. Epub 2024 Dec 6.
本文引用的文献
1
Comparison of the clinical outcomes of patients with NSAID-exacerbated respiratory disease receiving aspirin or biologicals.比较接受阿司匹林或生物制剂治疗的 NSAID 加重性呼吸道疾病患者的临床结局。
J Asthma. 2023 Oct;60(10):1885-1894. doi: 10.1080/02770903.2023.2196567. Epub 2023 Apr 21.
2
Evaluating treatment response to mepolizumab in patients with severe CRSwNP.评估美泊利珠单抗治疗重度 CRSwNP 患者的应答情况。
Rhinology. 2023 Apr 1;61(2):108-117. doi: 10.4193/Rhin22.200.
3
Mepolizumab targets multiple immune cells in aspirin-exacerbated respiratory disease.美泊利珠单抗靶向阿司匹林加重性呼吸系统疾病中的多种免疫细胞。
J Allergy Clin Immunol. 2021 Aug;148(2):574-584. doi: 10.1016/j.jaci.2021.05.043. Epub 2021 Jun 16.
4
Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial.美泊利单抗治疗伴有鼻息肉的慢性鼻-鼻窦炎（SYNAPSE）：一项随机、双盲、安慰剂对照、3 期临床试验。
Lancet Respir Med. 2021 Oct;9(10):1141-1153. doi: 10.1016/S2213-2600(21)00097-7. Epub 2021 Apr 16.
5
Efficacy of dupilumab in patients with aspirin-exacerbated respiratory disease and previous inadequate response to anti-IL-5 or anti-IL-5Rα in a real-world setting.在真实世界中，度普利尤单抗治疗阿司匹林加重的呼吸系统疾病患者及既往抗IL-5或抗IL-5Rα治疗反应不佳患者的疗效
J Allergy Clin Immunol Pract. 2021 Jul;9(7):2910-2912.e1. doi: 10.1016/j.jaip.2021.02.020. Epub 2021 Feb 22.
6
Dexpramipexole depletes blood and tissue eosinophils in nasal polyps with no change in polyp size.右普拉克索可减少鼻息肉中的血液和组织嗜酸性粒细胞，而息肉大小无变化。
Laryngoscope. 2019 Feb;129(2):E61-E66. doi: 10.1002/lary.27564. Epub 2018 Oct 4.
7
Cytokines in Chronic Rhinosinusitis. Role in Eosinophilia and Aspirin-exacerbated Respiratory Disease.慢性鼻-鼻窦炎中的细胞因子。在嗜酸性粒细胞增多和阿司匹林诱发的呼吸道疾病中的作用。
Am J Respir Crit Care Med. 2015 Sep 15;192(6):682-94. doi: 10.1164/rccm.201412-2278OC.
8
Survey-Defined Patient Experiences With Aspirin-Exacerbated Respiratory Disease.调查定义的阿司匹林加重性呼吸系统疾病患者体验。
J Allergy Clin Immunol Pract. 2015 Sep-Oct;3(5):711-8. doi: 10.1016/j.jaip.2015.03.001. Epub 2015 Apr 7.
9
Mepolizumab treatment in patients with severe eosinophilic asthma.美泊利珠单抗治疗严重嗜酸性粒细胞性哮喘患者。
N Engl J Med. 2014 Sep 25;371(13):1198-207. doi: 10.1056/NEJMoa1403290. Epub 2014 Sep 8.
10
Medical and surgical considerations in patients with Samter's triad.阿司匹林三联征患者的医学与外科考量
Am J Rhinol. 2006 Nov-Dec;20(6):573-6. doi: 10.2500/ajr.2006.20.2913.
Zotero 插件